Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary J R Cook

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2025
[<sup>18</sup>F]-Labeled Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Staging and Restaging Patients With Breast CancerDavid Groheux, Sofia C Vaz, Lioe-Fee de Geus-Oei, et al.
Cancers|December 23, 2022
Non-Small Cell Lung Cancer (NSCLC) in Young Adults, Age < 50, Is Associated with Late Stage at Presentation and a Very Poor Prognosis in Patients That Do Not Have a Targeted Therapy Option: A Real-World StudyDaniel Johnathan Hughes, Matthaios Kapiris, Andreja Podvez Nevajda, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 13, 2024
Joint EANM-SNMMI guideline on the role of 2-[<sup>18</sup>F]FDG PET/CT in no special type breast cancer : (endorsed by the ACR, ESSO, ESTRO, EUSOBI/ESR, and EUSOMA)Sofia C Vaz, John Patrick Pilkington Woll, Fatima Cardoso, et al.
British Journal of Cancer|April 5, 2025
PD-L1 imaging with [<sup>99m</sup>Tc]NM-01 SPECT/CT is associated with metabolic response to pembrolizumab with/without chemotherapy in advanced lung cancerDaniel Johnathan Hughes, Gitasha Chand, Jessica Johnson, et al.
AIDS (London, England)|December 7, 2023
Bone turnover change after randomized switch from tenofovir disoproxil to tenofovir alafenamide fumarate in men with HIVAmelia E B Moore, James E Burns, Deirdre Sally, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 2, 2025
Diagnostic performance of quantitative measures from [<sup>18</sup>F]FDG PET/CT, [<sup>18</sup>F]FEC PET/CT, and DW-MRI in the detection of lymph node metastases in endometrial and cervical cancer: data from the MAPPING studyBen G King, Nishat Bharwani, William Wilson, et al.
Journal for Immunotherapy of Cancer|June 15, 2023
Intratumoral pan-ErbB targeted CAR-T for head and neck squamous cell carcinoma: interim analysis of the T4 immunotherapy studySophie Papa, Antonella Adami, Michael Metoudi, et al.
BMC Medicine|January 24, 2025
Translation of PET radiotracers for cancer imaging: recommendations from the National Cancer Imaging Translational Accelerator (NCITA) consensus meetingMartina A McAteer, Daniel R McGowan, Gary J R Cook, et al.
Radiology|February 6, 2024
The Image Biomarker Standardization Initiative: Standardized Convolutional Filters for Reproducible Radiomics and Enhanced Clinical InsightsPhilip Whybra, Alex Zwanenburg, Vincent Andrearczyk, et al.
Radiology|March 11, 2020
The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based PhenotypingAlex Zwanenburg, Martin Vallières, Mahmoud A Abdalah, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2025
[<sup>18</sup>F]-Labeled Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Staging and Restaging Patients With Breast CancerDavid Groheux, Sofia C Vaz, Lioe-Fee de Geus-Oei, et al.
Cancers|December 23, 2022
Non-Small Cell Lung Cancer (NSCLC) in Young Adults, Age < 50, Is Associated with Late Stage at Presentation and a Very Poor Prognosis in Patients That Do Not Have a Targeted Therapy Option: A Real-World StudyDaniel Johnathan Hughes, Matthaios Kapiris, Andreja Podvez Nevajda, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 13, 2024
Joint EANM-SNMMI guideline on the role of 2-[<sup>18</sup>F]FDG PET/CT in no special type breast cancer : (endorsed by the ACR, ESSO, ESTRO, EUSOBI/ESR, and EUSOMA)Sofia C Vaz, John Patrick Pilkington Woll, Fatima Cardoso, et al.
British Journal of Cancer|April 5, 2025
PD-L1 imaging with [<sup>99m</sup>Tc]NM-01 SPECT/CT is associated with metabolic response to pembrolizumab with/without chemotherapy in advanced lung cancerDaniel Johnathan Hughes, Gitasha Chand, Jessica Johnson, et al.
AIDS (London, England)|December 7, 2023
Bone turnover change after randomized switch from tenofovir disoproxil to tenofovir alafenamide fumarate in men with HIVAmelia E B Moore, James E Burns, Deirdre Sally, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 2, 2025
Diagnostic performance of quantitative measures from [<sup>18</sup>F]FDG PET/CT, [<sup>18</sup>F]FEC PET/CT, and DW-MRI in the detection of lymph node metastases in endometrial and cervical cancer: data from the MAPPING studyBen G King, Nishat Bharwani, William Wilson, et al.
Journal for Immunotherapy of Cancer|June 15, 2023
Intratumoral pan-ErbB targeted CAR-T for head and neck squamous cell carcinoma: interim analysis of the T4 immunotherapy studySophie Papa, Antonella Adami, Michael Metoudi, et al.
BMC Medicine|January 24, 2025
Translation of PET radiotracers for cancer imaging: recommendations from the National Cancer Imaging Translational Accelerator (NCITA) consensus meetingMartina A McAteer, Daniel R McGowan, Gary J R Cook, et al.
Radiology|February 6, 2024
The Image Biomarker Standardization Initiative: Standardized Convolutional Filters for Reproducible Radiomics and Enhanced Clinical InsightsPhilip Whybra, Alex Zwanenburg, Vincent Andrearczyk, et al.
Radiology|March 11, 2020
The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based PhenotypingAlex Zwanenburg, Martin Vallières, Mahmoud A Abdalah, et al.
Pageof 13